Discovery of C19-9 as a novel non-RGD inhibitor of αvβ3 to overcome enzalutamide resistance in castration-resistant prostate cancer.
Xiaocong PangXiaojiao SunYanlun GuXu HeJingcheng ZhouSong SongJixin ZhangJie XiaZhenming LiuYimin CuiPublished in: Signal transduction and targeted therapy (2023)